Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Oxford Nanopore Technologies Plc (ONT) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering.
Oxford Nanopore Technologies Plc (Oxford Nanopore), formerly Oxford NanoLabs Ltd, develops disruptive, electronic, and single-molecule sensing systems. The company's products include SmidgION, Flongle, MinION, PromethION and GridION used for the analysis of DNA, RNA, proteins, small molecules and other types of molecules. Its products find applications in various areas of research such as microbiology, environmental research, microbiome, basic genome research, human genetics, cancer research, clinical research, plant research, transcriptome analysis, population genomics and animal research.
The company also offers support, certification and training services. It works in partnership with various academic and industry research groups to launch new genomic and medical applications through its nanopore technology. Oxford Nanopore is headquartered in Oxford, England, the UK.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
Report Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Oxford Nanopore Technologies Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Key Report Features:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Key Topics Covered:
- Oxford Nanopore Technologies Plc Company Overview
- Oxford Nanopore Technologies Plc Company Snapshot
- Oxford Nanopore Technologies Plc Pipeline Products and Ongoing Clinical Trials Overview
- Oxford Nanopore Technologies Plc - Pipeline Analysis Overview
- Oxford Nanopore Technologies Plc - Key Facts
- Oxford Nanopore Technologies Plc - Major Products and Services
- Oxford Nanopore Technologies Plc Pipeline Products by Development Stage
- Oxford Nanopore Technologies Plc Pipeline Products Overview
- LamPORE COVID-19 Test Kit
- LamPORE COVID-19 Test Kit Product Overview
- LamPORE Respiratory Panel
- LamPORE Respiratory Panel Product Overview
- Nanopore Sequencing Software
- Nanopore Sequencing Software Product Overview
- Portable DNA Sequencing Tool
- Portable DNA Sequencing Tool Product Overview
- SmidgION
- SmidgION Product Overview
- TraxION
- TraxION Product Overview
- Oxford Nanopore Technologies Plc - Key Competitors
- Oxford Nanopore Technologies Plc - Key Employees
- Oxford Nanopore Technologies Plc - Key Employee Biographies
- Oxford Nanopore Technologies Plc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Oxford Nanopore Technologies Plc, Recent Developments
- May 28, 2024: American Association of Cancer Research: Oxford Nanopore showcases transformative technology for accelerating oncology research
- May 23, 2024: Oxford Nanopore Technologies : London Calling Technology Update
- Mar 11, 2024: Oxford Nanopore Technologies and SeqOne Partner to Support Interpretation of Nanopore Sequencing in Clinical Use
- Mar 07, 2024: Oxford Nanopore launches PromethION 2 Integrated into open early access
- Feb 29, 2024: Oxford Nanopore Technologies Announces Directorate Change
- Jan 22, 2024: Oxford Nanopore Technologies Announces Expansion of Leadership Team
- Nov 30, 2023: New Genomic Funding Awarded in Australia to Boost National Rare Disease Research Programme, Using Oxford Nanopore Technologies
- Oct 25, 2023: Oxford Nanopore Technologies and Saphetor Announce a New Partnership to Deliver Tertiary Analysis for Comprehensive Interpretation of Nanopore Sequencing
- Oct 23, 2023: Oxford Nanopore secures £70m from French diagnostics company
- Oct 19, 2023: bioMerieux Makes Strategic Investment in Oxford Nanopore
For more information about this company profile visit https://www.researchandmarkets.com/r/k7iz2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
